Recognising the importance of anaemia in COPD

T. Similowski (Paris, France)

Source: Annual Congress 2008 - COPD – the holistic perspective
Session: COPD – the holistic perspective
Session type: Symposium
Number: 140
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Similowski (Paris, France). Recognising the importance of anaemia in COPD. Annual Congress 2008 - COPD – the holistic perspective

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Viliam Meissner - 12.10.2008 12:50
Important topic.
Logic, explanatory presentation.
You must Login to comment this presentation.


Related content which might interest you:
Identifying asthma features in severe COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Proportion and impact of anemia in COPD patients
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


Clinical impact of anemia in patients with COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


The potential impact of anaemia of chronic disease in COPD
Source: Eur Respir J 2006; 27: 390-396
Year: 2006



Reasons of malnutrition development in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 163s
Year: 2006

Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Prevalence and determinants of anaemia in hospitalized elderly COPD patients
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008

Correction of the anemia of chronic disease among COPD patients
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


The impact of anemia on patients with chronic obstructive pulmonary disease in the community
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012

Haemoglobin level and its clinical impact in a cohort of patients with COPD
Source: Eur Respir J 2007; 29: 923-929
Year: 2007



Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004

Prevelance and the association of anaemia with clinical and functional parameters in patients with COPD who referred to a pulmonary rehabilitation programme
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012

Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

Prevelance of anemia in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006


Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

The complexities of patients with COPD
Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II
Year: 2014

Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020